After PSA screening, MRI-targeted vs. systematic biopsy detected fewer clinically insignificant prostate cancers.
Where this comes from
- Record sourced from PubMed, PMID 37011398.
- Also identified by DOI 10.7326/J23-0017.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hugosson J, Månsson M, Wallström J, et al. <b>Prostate cancer screening with PSA and MRI followed by targeted biopsy only.</b> N Engl J Med. 2022;387:2126-37. 36477032.
Medical subject headings
- Prostatic Neoplasms